The latest draft version of the vaccination plan was
circulated, highlighted sections in
the plan indicated key points where
changes had been made.
A1 – Aims and objectives
Simon Scanlan provided an
analysis of the likely costs involved in a voluntary or
The analysis was based on a variety of assumptions which
could be changed if
required. Three options were considered for England only:
1) a compulsory programme with full state supervision
3) a compulsory programme, audited by Animal
A voluntary programme (option 2) would be half the price of a
programme (option 3). It is unlikely that there would be
any resources available in
Animal Health for a fully supervised compulsory
programme (option 1).
Discussions were raised on vaccine wastage, which would depend on the
and the volume of the order. Simon Scanlan has been asked to pull
together data on
premises needing 20 dose bottles.
On compulsory vaccination, even retrieving the additional costs back
require an additional cost. Retrieving and redistributing funds
from the Commission
would also be a complex process. Kevin Pearce suggested
the scheme should be
promoted as practically compulsory, by creating pressure
on farmers regarding the
importance of vaccination to protect the
Action: Philip Reed to produce a short paper on the reasons behind
decision made for a voluntary and not a compulsory scheme.
B2 – Area and priorities in which vaccination will be carried
It will be important to vaccinate on known infected premises and
large cattle herds
due to their potential role in disease spread. It was
noted by Jane Gibbens that there
is an issue with newborn animals that cannot
be vaccinated because of their age.
Intervet’s studies are ongoing and
Alisdair King will provide clarity on the age
animals can be
Consideration will be given to extending zones after a certain period.
on the extent of zones will be kept under review.
B7 - Identification of vaccinated animals and
There was debate on whether vaccinated animals should be
with strong support from Scotland for the
identification of vaccinated animals. This
could be important for exit
strategy. Further discussion will continue at the next
5. Cost-benefit analysis
Section previously covered
under section 4 – vaccination plan.
6. Potential cost of vaccination
Gaps and questions
on the cost of the vaccination are still pending. Work will be
a recommended price, clarifying the mark-up wholesalers and vets
on the vaccine. A meeting will be held with the veterinary department
wholesalers. It was noted by Peter Morris that we need to be clear on
margins are on profits so there is transparency. Andrew Jones stated
that this was a complex area but would endeavour to provide as
much information as
possible. It is envisaged that information will be
available in the near future on the
Consideration of the plan is
currently in progress, further comments will be required
soon. A revised
version will be submitted to the Core Group and Science
A wider stakeholder meeting is scheduled soon for views and
the vaccine process. The next Working Group meeting will
report on the remaining
gaps, identifications, with a near-final version
provided of the plan to be discussed.
Members were thanked for their
Date and time of next meeting
Wednesday 23 January at 2pm,
sday 23 January at 2pm,
Page Street, LG20.